Search
XORTX Therapeutics Inc
XRTXAdd to Watchlist
2.120USD
+0.100+4.95%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.95MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Buy
Current Rating
70.000
Target Price
+2943.48%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
XORTX Therapeutics Inc
XRTX
1
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is XORTX Therapeutics Inc's price target?
Analysts forecast that XORTX Therapeutics Inc's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
What is the analyst rating for XORTX Therapeutics Inc?
Based on the ratings of XORTX Therapeutics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.